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Abstract— We proposed a novel convolutional restricted 
Boltzmann machine (CRBM)-based radiomic method for 
predicting pathologic complete response (pCR) to neoadjuvant 
chemotherapy treatment (NACT) in breast cancer. The method 
consists of extracting semantic features from CRBM network, and 
pCR prediction … It was evaluated on the dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI) data of 57 
patients and using the area under the receiver operating 
characteristic curve (AUC). Traditional radiomics features and 
the semantic features learned from CRBM network were 
extracted from the images acquired before and after the 
administration of NACT. After the feature selection, the support 
vector machine (SVM), logistic regression (LR) and random forest 
(RF) were trained to predict the pCR status. Compared to 
traditional radiomic methods, the proposed CRBM-based 
radiomic method yielded an AUC of 0.92 for the prediction with 
the images acquired before and after NACT, and an AUC of 0.87 
for the pretreatment prediction, which was increased by about 
38%. The results showed that the CRBM-based radiomic method 
provided a potential means for accurately predicting the pCR to 
NACT in breast cancer before the treatment, which is very useful 
for making more appropriate and personalized treatment 
regimens.   
 
Index Terms—Breast Cancer, DCE-MRI, Convolutional 
Restricted Boltzmann Machine, Pathological Complete Response, 
Neoadjuvant Chemotherapy 
 
I. INTRODUCTION 
REAST cancer is the most common malignant tumor for 
women. More than 2 million new cases of invasive breast 
cancer were diagnosed and 626 thousand patients were killed 
by breast cancer in 2018 [1],[2]. The early diagnosis and precise 
treatment are very important for increasing the survival rate of 
breast cancer patients.  
Traditional treatments for breast cancer in early stage include 
surgery, radiotherapy, and adjuvant systemic chemotherapy, etc. 
[3]. To decrease the rate of the cancer metastasis and increase 
the survival rate, in recent years, neoadjuvant chemotherapy 
treatment (NACT) has been used for patients with breast cancer 
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[4]. It was demonstrated that a good response to NACT enables 
the size of the tumor to be reduced, which might increase the 
chance of breast-conserving surgery, allow eradicating micro-
metastatic disease, and be useful to test the effectiveness of 
drugs used for the adjuvant chemotherapy [5]. Patients with 
pathological complete response (pCR) after NACT have a 
better prognosis and longer survival rate than those with non-
pCR [6], [7]. Although most patients respond positively to 
NACT, showing a pathological complete response, there are 
still a majority of patients who remain resistant to NACT [8]. 
Therefore, predicting pCR and non-pCR status before NACT is 
very important to help doctors to make precise and personalized 
treatment regime for different patients, especially to help those 
non-responders to NACT to avoid ineffective therapies and 
missing the best treatment opportunity.  
Conventionally, pCR status is examined from the surgical 
specimen of patients after the initial NACT completion in a 
histological manner, or evaluated with mammography and 
ultrasonography. With the development of imaging technology, 
dynamic contrast-enhanced magnetic resonance imaging 
(DCE-MRI) has become a promising imaging modality to 
assess the pCR after NACT due to its high sensitivity to 
angiogenic variations in the tumors [9]. The researches 
demonstrated that, after a short period of NACT, the changes in 
the kinetic parameter of DCE-MRI is highly related to pCR 
prediction [10]. Although these methods can provide an early 
response prediction following the initial NACT administration, 
it is unfortunately not possible to avoid ineffective treatment for 
the non-responders. Therefore, predicting accurately the pCR in 
an noninvasive manner before NACT is highly desired.  
Recently, with the emerging of radiomics that attempts to 
characterize cancer properties by extracting high-throughput of 
quantitative features from multimodal images, more and more 
works about pCR prediction in breast cancer based on 
radiomics have been reported. For instance, Sun et al. extracted 
several DCE-MRI parameters from the images scanned after 
the first cycle of NACT to establish pCR prediction model 
using a logistic regression method; the prediction accuracy can 
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be up to 0.91 [11], which validates the potential of DCE-MRI 
for early prediction of pCR in breast cancer. Following this 
work, researchers tried to extract a large number of image 
textural features instead of kinetic features to predict pCR to 
NACT in breast cancer. Michoux et al. used gray-level co-
occurrence matrix (GLCM) and gray-level run-length matrix 
(GLRLM) features to predict the pCR to NACT [12], the AUC 
of which can be up to 0.70. Giannini et al. extended the GLCM 
and GLRLM features into three-dimension (3D) to get a higher 
AUC of about 0.72 [13]. They succeeded in increasing the AUC 
to 0.84 by using several feature selection algorithms [14]. 
Considering that multimodal images could provide much more 
information, Liu et al. predicted the pCR with multimodal 
images for the patients who received NACT for 4 cycles, 6 
cycles and 8 cycles, respectively [15].  
These researches demonstrated that radiomics is a powerful 
means for predicting the pCR status to NACT. However, almost 
all the prediction methods mentioned above are based on the 
imaging data acquired after the administration of NACT. As far 
as we know, only a few works have investigated pCR prediction 
with the images acquired before NACT. Lin et al. predicted the 
PCR status with a higher AUC of 0.91 by combining the 
background parenchymal enhancement (BPE) and radiomic 
features extracted from the images acquired before NACT [16]. 
Plecha et al. further improved the prediction AUC by extracting 
radiomic features from both intratumoral and peritumoral 
regions in the peak enhanced images acquired before NACT 
[17]. Although they are able to get a higher prediction AUC, the 
requirements for image acquisition is a little strict. How to use 
fewer regularly acquired image data to get a higher prediction 
AUC is still a challenge.  
Taking into account the advantages of unsupervised learning 
models in feature learning, in this work, we proposed to use 
convolutional restricted Boltzmann machine (CRBM) to extract 
semantic features instead of traditional radiomic features to 
increase pCR prediction accuracy with few images, especially 
for the pCR prediction before NACT. To evaluate the 
performance of the proposed method, the prediction accuracies 
obtained with traditional radiomic features and CRBM features 
are compared quantitatively.   
II. MATERIALS AND METHODS 
A. Data Description 
The dataset used in this study is named ISPY-1, which 
includes the DCE-MRI data of 222 patients [18]-[20]. It can be 
downloaded from the website of https://wiki.cancerimaging 
archive.net/display/Public/ISPY1. Considering that some slices 
do not have the labeled region of interest (ROI), 12176 slices 
with ROI were selected and taken as our dataset, which contains 
4038 pCR samples and 8138 non-pCR samples. Breast DCE-
MRI examination for each patient was performed respectively 
before administration of NACT (baseline), 1-3 days after 
NACT (early treatment), between anthracycline 
cyclophosphamide treatment and taxane therapy (inter-
regimen), and after the final chemotherapy treatment and prior 
to surgery (pre-surgery). All the images were acquired with a 
1.5 T scanner with a 3D fat-suppressed gradient echo sequence, 
in which, TR≤20 ms, TE = 4.5 ms, flip angle ≤45º, the field of 
view is about 16 to 18 cm, the minimum matrix is 256x192 with 
in-plane spatial resolution being less than 1 mm, and the slice 
thickness is less than 2.5 mm. The images were acquired once 
before contrast injection and repeated at least twice following 
injection. 
Besides the imaging data, the clinical and pathological 
characteristics of the patients are given in TABLE I, including 
the patients’ number, age, cancer subtypes, and imaging stages. 
Among these pathological characteristics, HER2 is an 
important factor for choosing the treatment strategy of breast 
cancer. Therefore, we compared the prediction accuracy of 
different methods for patients with HER2+ status. In addition, 
to compensate the insufficiency of current pCR prediction, we 
further divided the imaging data into four groups according to 
imaging stages, including baseline, early treatment, inter-
regimens, and pre-surgery. 
 
 
B. Traditional Radiomic Pipeline for PCR Prediction 
The traditional process of radiomics consists of four main 
steps. Firstly, the image ROI was delineated automatically or 
manually by radiologists. Secondly, a large number of human-
defined image features were extracted, including first-order 
image features [21], [22] such as mean intensity, variance, 
skewness and kurtosis, the geometrical features (shape, volume, 
length, etc.), textual features (gray level co-occurrence 
matrix—GLCM and gray-level run-length matrix—GLRLM.) 
[23], and wavelet features [24]. Feature extraction 
programming was implemented in Matlab 2016a. A total of 335 
quantitative features were automatically extracted from 
delineated ROIs to describe tumor phenotype characteristics. 
Thirdly, considering that the extracted features may be 
correlated and redundant, which will induce problems such as 
overfitting and poor generalization for the prediction model, 
TABLE I 
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF DIFFERENT STUDY 
POPULATIONS. 
 pCR Non-pCR 
Number of patients 17 36 
Number of slices 4038 8138 
Age (years)   
Mean 44.16 47.81 
Std 6.69 9.6 
Imaging stages and subtypes   
Baseline   
HR+,HER2- 4 23 
TN/HER2+ 13 13 
Early treatment   
HR+,HER2- 3 20 
TN/HER2+ 13 11 
Inter-regimens   
HR+,HER2- 4 22 
TN/HER2+ 11 12 
Pre-surgery   
HR+, HER2- 4 23 
TN/HER2+ 13 13 
NB: pCR denotes the pathological response to NAC, and Non-pCR the no 
response to NAC. 
feature selection was performed after the feature extraction. 
There are numerous feature selection algorithms; in the present 
work, we used partial least squared(PLS) method [25] to reduce 
feature dimension. Finally, based on the selected features, a 
classifier is employed for predicting. Currently, logistic 
regression (LR) [26], support vector machine (SVM) [27], 
random forest (RF) [28] are typical algorithms for classification. 
Therefore, these three algorithms were used for predicting pCR 
status. The overview of radiomic frameworks for pCR 
prediction is given in Fig. 1. 
 
 
 
C. Radiomics Based on Convolutional Restricted Boltzmann 
Machine for PCR Prediction 
As mentioned above, the predefined features in traditional 
radiomics may be insufficient to represent tumor phenotype 
characteristics and consequently influence the prediction 
accuracy. To deal with this issue, we propose to use CRBM to 
extract more semantic features. The framework of the CRBM 
features-based prediction is illustrated in Fig. 2. 
 
 
 
With the segmented image ROI, some CRBM feature maps 
were obtained by the convolutions with convolutional kernels 
trained by CRBM method. Then, a convolution with kernel size 
of 1*1 were adopted to combine some features and reduce 
dimensions of CRBM feature maps. For the last two steps, we 
implement the same feature selection and classification method 
as traditional radiomics features based method. 
The standard restricted Boltzmann machine (RBM) is an 
undirected probability graph model that contains a visible layer 
v  and a hidden layer h , where each unit in the visible layer is 
fully connected to the hidden units, but the units in the same 
layer are not connected, as illustrated in Fig. 3. RBM is devoted 
to learning the probability distribution of visible and hidden 
unites. In the application of image feature extraction, the units 
in the visible layer can be viewed as image pixels and those in 
the hidden layer as image features. 
 
 
 
RBM is an energy-based model, which means that the 
probability of variables in RBM is determined by the joint 
energy of hidden and visible units (v,h)E , namely, 
 
 P(v,h) =
exp(-E(v,h))
Z
 , (1) 
 
where Z  is a normalization constant defined by: 
 
 Z = exp(-E(v,h))
h
å
v
å .  (2) 
 
In the present study, the visible units and hidden units are 
both binaries. Thus, the energy ( , )E v h  can be expressed as:  
 
 ,,( , ) i i i i j j j ji i j jE v h b v vW h c h= − −   ,  (3) 
 
where 
iv  and jh  represent respectively the 
thi  and jth  units in 
visible and hidden layers, 
jb
 and c j  are the bias items for units 
iv  and jh , and ijW  is the connection weights between iv  and jh . 
The probability inference from visible layer to hidden layer 
or vice versa can be formulated as: 
 
 
,
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where ( ) 1/ (1 exp( ))sigm x x= + −  is the logistic sigmoid function. 
From the RBM structure, we can observe that all the units in 
the visible layer are related to all the units in the hidden layer. 
Such dense connection is not practical for extracting features 
from big images. To overcome this problem, convolutional 
RBMs (CRBMs) were proposed, which benefit the weight 
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Fig. 2. Framework of CRBMs for pCR prediction. 
Hidden Layer h
Visble Layer v
Fig. 3. Schematic diagram of standard RBM model. 
sharing merits from convolution operations [29], the structure 
of which is depicted in Fig. 4.  
 
 
 
We can see that the connections between hidden and visible 
layers are realized by several convolutional kernels 
mW , which 
results in a hidden layer representing the image feature map 
mh . 
If all the pixels in the input image share one bias b  and all the 
pixels in the thm  hidden feature map share the same bias 
mc , 
the probability inference can be rewritten as: 
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m
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where 
mW  is the horizontally and vertically flipped filter of mW , 
m
ijh denotes the pixel value located at 
thi  row and thj  column 
of the thm  hidden feature map, and 
ijv represents the 
corresponding pixel value of the input image.  
The purpose of RBM or CRBM is to find a set of parameters 
{ , , }W b c =  that minimizes the overall energy ( , )E v h  with 
respect to the training data. Thus, the feature maps generated 
from the hidden layer can represent the input images perfectly. 
According to (1), minimizing the energy is equivalent to 
maximizing the log-likelihood function L : 
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The parameters are updated using the gradient descent 
method: 
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:
P v
  


= +

 , (7) 
 
where   indicates the learning rate. Eq. (6) shows that the 
calculation of ( , )
,
E v h
h v
e−  requires knowing the joint probability 
( , )P v h  which is unfortunately infeasible to infer. To cope with 
this problem, we used the contrastive divergence (CD) method 
of Hinton [30] , with which the updating of parameters can be 
written as: 
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In (8), kv  and kh  are obtained by Gibbs sampling for k 
times. 
hn  indicates the number of hidden nodes. Namely, given 
the input, the initial state of the hidden unit 0h is sampled using 
the distribution 0 0( | )p h v  as expressed in (5), where 0v  is the 
input image. Then, keeping the hidden unit unchanged, the 
status of visible units is updated as 1v  according to 1 1( | )p v h . 
This alternating sampling process is repeated for k times to 
obtain kv  and kh . The detailed parameter updating algorithm 
is given in Algorithm 1 as follows.  
 
 
 
D. Prediction Evaluation 
The performance of pCR prediction with traditional and 
CRBM-based radiomics was evaluated in terms of receiver 
operating characteristic (ROC) curve, area under curve (AUC), 
sensitivity, specificity, and accuracy. ROC is created by 
plotting true positive rate (TPR) against false positive rate (FPR) 
at various thresholds in a classifier. AUC is derived from ROC, 
which is the area under the ROC curve and specifies the 
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Fig. 4. Schematic diagram of convolutional RBM model. 
 
classification accuracy. The bigger the AUC, the more accurate 
the classification. Sensitivity represents the correct 
classification rate of positive samples while specificity 
represents the correct classification rate of negative samples. 
Due to the fact that AUC is not sensitive to sample 
characteristics such as the unbalance of sample classes, it is 
often used to evaluate the performance of the classifier for the 
unbalanced dataset. The ROC and AUC are usually applied in 
dichotomous problem. 
III. EXPERIMENTAL RESULTS 
A. Experimental Setup 
In order to compare fairly the performance of traditional 
radiomics and CRBM-based radiomics for the prediction of 
pCR to NACT of breast cancer, all the experiments were 
implemented and evaluated with the same training and 
validation datasets. That is, the evaluation was performed using 
4-fold cross-validation, in which 3044 samples were taken as 
the validation dataset and 9132 samples as the training dataset. 
Considering the fact that the image features extracted from 
CRBM are highly dependent on the input image size, in the 
comparison experiments, the input of CRBM was divided into 
two cases: one is the whole slice with a size of 256×256, and 
the other is the image patch with a size of 32×32.  
The structure of CRBM used in the present work included 
one hidden layer, which was obtained by the convolutions 
between the input image and 64 convolutional kernels of size 
5×5, and each convolution kernel had its own bias. During the 
training, the learning rate of CRBM was set as 1e-4. Under this 
setting, the dimension of feature maps derived from CRBM was 
252×252×64 when the input was the whole slice and turned to 
28×28×64 when the input was the image patch. To reduce the 
dimension and combine some features, a convolution with 
kernel size of 1×1 was performed, which resulted in a feature 
map of size 252×252 or 28×28. The feature map was flattened 
and taken as the input of classifiers. As to traditional radiomics, 
we extracted 335 features. Whatever the features extracted from 
CRBM or traditional radiomics, they were highly correlated. 
Therefore, a feature selection process was performed to reduce 
the number of features to 20. 
B. Quantitative Comparison of Overall PCR Prediction 
Accuracy 
As mentioned above, the features that were inputted into the 
classifiers were divided into three groups: features defined in 
traditional radiomics, features extracted from image-based 
CRBM, and features from patch-based CRBM. To evaluate 
fairly the influence of image feature extraction methods on 
prediction accuracy, three classifiers including RF, SVM and 
LR were used. The ROCs of three classifiers for different image 
features are given in Fig. 5. In the ROC curves, the middle black 
curve represents the dividing line with AUC of 0.5, the blue 
curve indicates the ROC obtained with features from traditional 
radiomics, the green one the ROC from patch-based CRBM, 
and the orange the ROC from image-based CRBM. It can be 
seen that the prediction with traditional radiomic features has 
the worst performance for all the classifiers. The prediction 
accuracy using the features extracted from CRBM is much 
better than traditional radiomic features, especially for SVM 
and LR classifiers. Moreover, when these two classifiers are 
used, the prediction with the features extracted from patch-
based CRBM is better than that with the features extracted from 
image-based CRBM. But for the RF classifier, the performance 
of patch-based CRBM is a little worse than that of image-based 
CRBM. 
 
 
 
To further quantitatively compare the pCR prediction 
performance with different features, the accuracy, sensitivity, 
specificity, and AUC were calculated and given in TABLE II. 
We observe that for most metrics, CRBM features led to better 
performance than traditional radiomic features. The prediction 
accuracy was increased by about 13% with SVM and LR, and 
7% with RF.
 
 
(a)RF                                                                        (b) SVM                                                                            (c) LR 
Fig. 5. Comparison of ROCs for different classifiers with different image features. 
 
 
To better get insights into this effect, the feature discrepancy 
between positive samples (pCR) and negative samples (non-
pCR) is given in Fig. 6, where the height of bars represents the 
feature discrepancy, the red and black points indicate 
respectively the feature values of positive and negative samples. 
It is seen that the discrepancy in features extracted form CRBM 
is much more obvious than that extracted from traditional 
radiomics. This explains well why the prediction based on the 
features extracted from CRBM is better than the traditional 
radiomics.
 
 
 
C. Quantitative Comparison of PCR Predictions Using the 
Images Acquired at Different Times 
The accuracy of pCR prediction is highly related to the breast 
cancer subtypes and imaging stages. Clinical experiments 
demonstrated that patients with different subtypes would 
respond to NACT in different ways. Generally, the patients with 
triple negative (TN) or human epidermal growth factor 2 
positive (HER2+) breast cancer would get pCR more easily [31]. 
As to the imaging stages, the pCR prediction based on images 
acquired in baseline stage (before NACT) is much harder than 
using images acquired after NACT. That is why the pCR 
prediction before NACT was rarely reported. To further 
validate the performance of the proposed method, we divided 
the imaging data into five groups according to image 
acquisition times, and the corresponding predictions based on 
these images were respectively implemented. Considering the 
influence of data balance on prediction performance, only the 
images of the patients with TN and HER2+ breast cancer were 
used in this group of experiments. The LR classifier was chosen 
to compare the performance of features extracted from 
traditional radiomics and patch-based CRBM radiomics. The 
quantitative results were given in TABLE III.
 
TABLE II 
QUANTITATIVE COMPARISON OF DIFFERENT CLASSIFIERS FOR   PCR PREDICTION WITH DIFFERENT FEATURES IN TERMS OF VARIOUS METRICS 
 Accuracy Sensitivity Specificity AUC  
LR     
Radiomics 0.68 0.67 0.69 0.75 
Image-based CRBM 0.76 0.82 0.73 0.87 
Patch-based CRBM 0.83 0.83 0.83 0.92 
SVM     
Radiomics 0.67 0.72 0.64 0.75 
Image-based CRBM 0.74 0.85 0.68 0.87 
Patch-based CRBM 0.81 0.85 0.78 0.91 
RF     
Radiomics 0.65 0.51 0.73 0.66 
Image-based CRBM 0.74 0.68 0.77 0.80 
Patch-based CRBM 0.72 0.58 0.79 0.77 
 
 
Fig. 6. Comparison of the feature discrepancies of different image features. The height of bars represents the feature discrepancy. The red and black points 
indicate respectively the feature values of positive and negative samples.  
 
 
From TABLE III, it is observed that the accuracy of pCR 
prediction based on CRBM features was much higher than that 
based on traditional radiomic features for all the imaging stages. 
Especially at the stage of baseline, the AUC was increased by 
about 38%, which further validates that the semantic features 
extracted from CRBM are more appropriate for the pCR 
prediction before the initialization of NACT. 
IV. DISCUSSION 
This work proposed a radiomic method to improve the 
prediction accuracy of pCR to NACT in breast cancer. The 
method is based on using CRBM to extract more semantic 
features. The outperformance of CRBM-based radiomics 
demonstrated that the semantic features extracted from the deep 
learning model are beneficial for the prediction of pCR to 
NACT in breast cancer, especially for the pretreatment 
prediction. The prediction accuracy of the proposed method 
was significantly improved compared to the models based on 
traditional radiomic features. Although some existing models 
could yield an AUC up to 0.8 [14] or even 0.9 [16], they  are 
highly dependent on population size and imaging modalities. In 
contrast, when trained only with DCE-MRI images of about 40 
patients, the proposed prediction model produced a better pCR 
prediction accuracy. 
The experimental results demonstrated the importance of 
image features for the prediction using radiomics. Compared to 
conventionally defined features in the literature, such as shape, 
texture and geometrical features, the features learned from the 
CRBM network provide more representative information for 
the classification. In addition, thanks to the convolution 
operations, the features extracted from CRBM allow us to 
account for the correlation between different samples. This 
explains the better performance of the proposed method. Since 
the features extracted from CRBM were related to input image 
size, we analyzed the influence of the latter on the prediction 
accuracy. The experimental results showed that smaller patches 
convolved with small convolutional kernels yield better image 
features for the prediction. 
Despite the high performance of CRBM-based features in 
predicting the pCR to NACT, there are still several limitations 
in the present work. Firstly, previous studies reported that the 
pCR prediction was related to receptor types, such as the status 
of HER2, HR and ER [32]. However, due to the unbalance of 
the dataset used (as indicated in Table 1) for the patients with 
HR+ and HER2-, namely, the number of pCR and non-pCR of 
this group are 4 and 23 respectively; the pCR prediction for 
such group was not analyzed. Secondly, it is well known that 
CRBM is sensitive to prior distribution; so considering the 
influence of different prior distributions would be interesting in 
the future. Thirdly, the validation of the proposed model was 
performed with the same cohort, which would degrade the 
statistical power of our model. In light of the merits of multiple 
imaging modalities, it would be useful to refine the proposed 
method to get more accurate and general pCR prediction 
models with more image datasets acquired from different 
centers. 
V. CONCLUSIONS 
We proposed a novel CRBM-based radiomic method for 
predicting pCR to NACT in breast cancer before treatment. The 
method uses the semantic features extracted from CRBM 
instead of the human-defined features as done in traditional 
radiomics to predict pCR status. The experimental results 
demonstrated that the proposed radiomics achieved better 
performance than traditional radiomics, especially for the 
pretreatment prediction, the AUC of which is increased by 
about 38%. That suggests its use as a potential powerful tool for 
clinical pCR predictions to NACT in breast cancer. 
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